XML 62 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisition of Tetraphase Pharmaceuticals, Inc - Summary of Purchase Price Allocation as of Acquisition Date (Details) - USD ($)
$ in Thousands
Jul. 28, 2020
Sep. 30, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Goodwill   $ 20,123 $ 20,123
Tetraphase Pharmaceuticals, Inc.      
Business Acquisition [Line Items]      
Cash $ 42,990    
Fair Value of CVRs 2,610    
Total Purchase Price 45,600    
Cash and cash equivalents 8,778    
Accounts receivable 1,187    
Inventory 4,767    
Prepaid expenses and other current assets 1,218    
Property and equipment 58    
Right-of-use lease assets 2,302    
Restricted cash 699    
Identifiable intangible assets 15,520    
Goodwill 20,123    
Accounts payable (1,400)    
Accrued expenses (2,979)    
Lease liabilities, current portion (967)    
Lease liabilities, less current portion (1,420)    
Other noncurrent liabilities $ (2,286)